Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 7/20 | 0.52 |
| ▸ | CALCR | P30988 | 7/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.50 |
| ▸ | KDM1A | O60341 | 2/20 | 0.48 |
| ▸ | STAT3 | P40763 | 1/20 | 0.48 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29679558 | 0.94 | OPRM1 (0.52) | RAMP3CALCROPRM1OPRK1KDM1A | |
| SCHEMBL29680174 | 0.93 | RAMP3 (0.52) | RAMP3CALCROPRM1OPRK1 | |
| SCHEMBL29612003 | 0.92 | STAT3 (0.51) | OPRM1OPRK1STAT3 | |
| SCHEMBL30974406 | 0.90 | RAMP3 (0.55) | RAMP3CALCRKDM1A | |
| SCHEMBL29611483 | 0.88 | MAPK8 (0.51) | RAMP3CALCROPRM1OPRK1 | |
| SCHEMBL30974226 | 0.88 | RAMP3 (0.50) | RAMP3CALCRKDM1AKEAP1 | |
| SCHEMBL29679604 | 0.88 | RAMP3 (0.57) | RAMP3CALCR | |
| SCHEMBL30345087 | 0.87 | OPRM1 (0.53) | OPRM1OPRK1KDM1A | |
| SCHEMBL31590961 | 0.87 | OPRM1 (0.53) | OPRM1OPRK1KDM1A | |
| SCHEMBL30974402 | 0.87 | NPY2R (0.55) | RAMP3CALCROPRM1OPRK1KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022069704-A2 | IMMUNODIAGNOSTIC AGENTS AND METHODS FOR THE DETECTION AND DIFFERENTIATION OF CORONAVIRUS INFECTIONS | INSTITUT FÜR MOLEKULARE DIAGNOSTIK UND BIOANALYTIK (IMDB) GGMBH (DE) | 2022-04-07 | — | — | WO | disclosed |